ClinicalTrials.gg
RecruitingNCT06288763Updated Mar 11, 2026

Nerve Transfer to Improve Function in High Level Tetraplegia

An observational study in Cervical Spinal Cord Injury and Tetraplegia, sponsored by Washington University School of Medicine. Recruiting at 10 sites in 2 countries. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by Washington University School of Medicine · Observational

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 122 studies in Quadriplegia with a site in United States — 43 open to participants now, 50 under way, 2 of them phase 3. Quadriplegia · United States.

Planned enrollment
7th of 10
30 · median 34
Started
2024
with 7 others
Observational
10 of 122
4 open now
Primary completion
2028-03
later than 33 of 49 live
Registered
100th of 122
by date
Lead sponsor
5 of 122
Washington University School of Medicine

Among the 122 studies in Quadriplegia with a site in United States, this one is the 7th largest by planned enrollment of the 10 observational ones that give a count, is one of 8 that started in 2024, is one of 10 observational ones, reaches primary completion later than 33 of the 49 other live ones, and was the 100th registered.

Quadriplegia

224 studies on the registry are indexed under Quadriplegia; 77 are open to participants now.

Browse Quadriplegia studies →

Open to participants now

43 of the 122 studies in Quadriplegia with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 43 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 57 Quadriplegia studies recruiting now, 17 (30%) set no upper age limit and 28 (49%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 122 studies in Quadriplegia with a site in United States, or all of them as a file.
02

Study summary

The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury.

Participants will:

  • undergo standard of care pre- and post-op testing and study exams
  • complete pre- and post-questionnaires
  • undergo standard of care nerve transfer surgeries
  • follow-up with surgeon at 6/12/18/24/36 and potentially at 48 months
  • attend therapy at local therapist for up to 2 years postop.
Read the detailed description

Restoration of function in patients with high tetraplegia has been an elusive clinical challenge. There is a critical need to find an effective reconstructive therapy/procedure which improves the upper extremity function in patients with high tetraplegia.

One pure motor nerve - spinal accessory nerve (SAN) remains a viable donor in high tetraplegia patients to successfully restore elbow flexion or extension. Elbow function can provide profound independence in mobility, ventilator management and may broaden the application of assistive therapies.

The two objectives of this study are:

  • Determine if SAN nerve transfer surgery can improve the reinnervation of bicep or tricep muscles in high tetraplegia patients.
  • Determine if SAN nerve transfer surgery can reanimate upper arm function and improve functional independence in patients with high tetraplegia.

Study Activities (including standard of care (SOC))

  • Electrodiagnosis pre-op (SOC)
  • Upper extremity maximum muscle testing (SOC)
  • Questionnaires (SOC and study-related (SR))
  • Exams by a study therapist (SR)
  • Neurological exam - ISNCSCI - (SOC)
  • Nerve Transfer Surgery to be determined by surgeon (SOC)
  • Follow-up visits with surgeon at 6/12/18/24/36 and potentially 48 months
  • post-op electrodiagnostic testing (SR)
  • post-op upper extremity maximum muscle testing (SOC)
  • post-op questionnaires
  • post-op therapy exams (SR)
03

Conditions studied

  • Cervical Spinal Cord Injury
  • Tetraplegia

Keywords

  • Spinal Cord Injury
  • Cervical spinal cord injury
  • Nerve Transfer Surgery
  • High Cervical Spinal Cord Injury
  • Cervical SCI
  • Tetraplegia
  • Quadriplegia
  • Nerve transfer
  • Spinal Accessory Nerve
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with high-level SCI injury (C1-C4) with complete lack of upper extremity function. Occurrence of injury should be greater than 6 months but fewer than 60 months

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-80 years of age
  • High cervical SCI (motor level C1-C4)
  • Motor complete SCI AIS grade A-B
  • Plateaued spontaneous recovery for at least 6 months of non-operative therapy
  • SCI greater than 6 months and fewer than 60 months since injury
  • At least MRC 4/5 donor strength
  • Mentally and physically willing and able to comply with evaluations

Exclusion criteria

Exclusion Criteria:

  • Active infection at the operative site or systemic infection
  • Any return or ongoing recovery of distal motor function
  • Significant joint contractures and/or limitations in passive range of motion in the arm
  • Mentally or physically compromised making it impossible to complete study activities
  • Immunologically suppressed
  • Currently undergoing long-term therapy
  • Active
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Elbow Dynamometry

    Change from baseline to 36-48 months post-surgery. Elbow dynamometer measures muscle strength using a handheld portable dynamometer

    Time frame: 36-48 months post-surgery

  2. Spinal Cord Independence Measure

    Change from baseline to 36-48 months post-surgery. SCIM addresses three specific areas of function in patients with SCI, 1) Self-care (feeding, grooming, bathing, and dressing), 2) respiration and sphincter management, and 3) patient's mobility abilities (transfers from bed and indoors/outdoors). SCIM guide clinicians in determining treatment goals/objectives for SCI patients helping therapists assess measurable outcomes in their functional independence. Scores range from 0-100 with a higher score representing better function.

    Time frame: 36-48 months post-surgery

  3. Motor strength in medical research council grade (MRC)

    Change in baseline to 36-48 Months post-surgery. The manual muscle testing is a reliable measure of motor strength when assessed by a trained examiner. Scores range from 0-5, with the highest number representing a better score.

    Time frame: 36-48 months post-surgery

  4. Electrodiagnosis (Nerve Conduction Study and Electromyography

    Change in baseline to 36-48 Months post-surgery. NCS/EMG evaluate neuromuscular health and inform the integrity of lower motor neurons.

    Time frame: 36-48 months post-surgery

Secondary outcomes

  1. Canadian Outcomes Performance Measure (COPM)

    Change from baseline to 36-48 months post-surgery. COPM is a validated outcome measure for SCI patients focusing on occupational performance in all areas of life. Scores range from 5-50 for performance and satisfaction. The higher scores reflect better performance and satisfaction.

    Time frame: 36-48 Months post-surgery

  2. Capabilities of Upper Extremity Questionnaire (CUE-Q)

    Change from baseline to 36-48 months post-surgery. CUE-Q detects changes in upper extremity function. Scores range from 32-224 with higher scores reflecting better function.

    Time frame: 36-48 Months post-surgery

  3. Modified Ashworth Scale (MAS)

    Change from baseline to 36-48 months post-surgery. MAS is a reliable measure for rating spasticity in SCI. Scores range from 0-32 with higher scores reflecting better function.

    Time frame: 36-48 Months post-surgery

  4. Spinal Cord Injury Quality of LIfe Questionnaire

    Change from baseline to 36-48 months post-surgery. SCI-QOL is designed to measure subjective quality of life in terms of satisfaction and importance. Range of scores is 0 to 30 with the higher scores reflecting a better quality of life..

    Time frame: 36-48 Months post-surgery

  5. International SCI Pain Basic Dataset (ISCIPBDS)

    Change from baseline to 36-48 months post-surgery. ISCIPBDS correctly classifies pain, determines its intensity and broad impact on daily activities. Lower scores reflect less pain/less interference in daily life.

    Time frame: 36-48 Months post-surgery

07

Study locations

9 of 10 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Aggregate data will be shared

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for Mar 2028, 48 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2024
First posted
Mar 1, 2024
StartActual
Feb 5, 2024
Primary completionEst.
Mar 1, 2028
CompletionEst.
Dec 31, 2028
Last update
Mar 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06288763
Responsible party
Wilson Z. Ray (MD - Principal Investigator, Washington University School of Medicine) — Principal investigator
First posted
Mar 1, 2024
Start date
Feb 5, 2024
Primary completion
Mar 1, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Mar 11, 2026

Study contacts

Linda Koester, BS
Contact
koesterl@wustl.edu
314-362-7368
Wilson Z. Ray, MD
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion